News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML
Photo of Hagop Kantarjian from mdanderson.org
Feb 8, 2024, 05:16

Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML

Hagop Kantarjian, Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared on X:

“Aza + ven + gilteritinib highly effective in newly diagnosed older FLT3-mutated AML: CR/CRi 96% and 18-month OS 72%. A new standard of care in this population.”

Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML

Hagop Kantarjian: A new standard of care in newly diagnosed older FLT3-mutated AML

Visit the article website.
Source: Hagop Kantarjian/X

A new standard of care AML cancer FLT3-mutated AML Hagop Kantarjian OncoDaily Oncology
Special Coverage
Insight
Dec 19, 2024, 08:12
Talha Badar: ASH24 abstract in acute leukemia and MDS
Blog
Dec 19, 2024, 08:08
T790M resistance mutations in EGFR+ lung cancer - EGFR Positive Lung Cancer UK
Positive
Dec 19, 2024, 08:03
Eric K. Singhi: Honored to be recognized as this year’s Emerging Leader by MUSC Alamni
Blog
Dec 19, 2024, 07:57
Marilyn Bui: Moffitt Cancer Center achieved the highest patient satisfaction score this year
Blog
Dec 19, 2024, 07:51
Laura Bukavina: The use of TMT for localized bladder cancer in octogenarians
Opinion
Dec 19, 2024, 07:45
Gustavo Viani: Stereotactic Body Radiation Therapy - Does scheduling matter?
Blog
Dec 19, 2024, 07:41
IMPACT Malignant Hematology Webinar on the evolving treatment landscape of lower-risk MDS - Vanderbilt-Ingram Cancer Center
Societies
Dec 19, 2024, 07:38
ASCOGI25 abstract titles are now available
Insight
Dec 19, 2024, 07:27
Geoffrey Shapiro Honored with MSCO Distinguished Researcher Award
Drugs
Dec 19, 2024, 07:24
U.S. FDA Grants Breakthrough Therapy Designation to Trodelvy®
Insight
Dec 19, 2024, 07:21
Post ASH24: The Most Important MPN Studies - IACH
Blog
Dec 19, 2024, 07:20
Kimryn Rathmell: Finding Hope - Ending Cancer as We Know It